

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of light stimulus involved in sensory perception (GO:0050962) | 5.23274059 |
| 2 | detection of light stimulus involved in visual perception (GO:0050908) | 5.23274059 |
| 3 | retinal rod cell development (GO:0046548) | 4.72416366 |
| 4 | retinal cone cell development (GO:0046549) | 4.64576661 |
| 5 | rhodopsin mediated signaling pathway (GO:0016056) | 4.48429191 |
| 6 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.29718609 |
| 7 | protein-chromophore linkage (GO:0018298) | 4.28884532 |
| 8 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 4.28476971 |
| 9 | mRNA splice site selection (GO:0006376) | 4.23902737 |
| 10 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.16430090 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.07085069 |
| 12 | striatum development (GO:0021756) | 4.06166689 |
| 13 | protein localization to synapse (GO:0035418) | 4.03904514 |
| 14 | photoreceptor cell development (GO:0042461) | 4.03263456 |
| 15 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.99830607 |
| 16 | eye photoreceptor cell development (GO:0042462) | 3.99592469 |
| 17 | regulation of alternative mRNA splicing, via spliceosome (GO:0000381) | 3.95676824 |
| 18 | positive regulation of granulocyte differentiation (GO:0030854) | 3.93382756 |
| 19 | synaptic vesicle exocytosis (GO:0016079) | 3.92761386 |
| 20 | photoreceptor cell maintenance (GO:0045494) | 3.86752968 |
| 21 | nonmotile primary cilium assembly (GO:0035058) | 3.83914996 |
| 22 | activated T cell proliferation (GO:0050798) | 3.83546601 |
| 23 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.79662647 |
| 24 | GMP metabolic process (GO:0046037) | 3.73639360 |
| 25 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.73480288 |
| 26 | alternative mRNA splicing, via spliceosome (GO:0000380) | 3.71663040 |
| 27 | neuron cell-cell adhesion (GO:0007158) | 3.63351423 |
| 28 | response to histamine (GO:0034776) | 3.61585083 |
| 29 | presynaptic membrane assembly (GO:0097105) | 3.58134909 |
| 30 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.54831912 |
| 31 | DNA deamination (GO:0045006) | 3.53784817 |
| 32 | negative T cell selection (GO:0043383) | 3.52857974 |
| 33 | pyrimidine dimer repair (GO:0006290) | 3.52844223 |
| 34 | glutamate receptor signaling pathway (GO:0007215) | 3.52498711 |
| 35 | histone H3-K4 trimethylation (GO:0080182) | 3.51186446 |
| 36 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.50169869 |
| 37 | negative thymic T cell selection (GO:0045060) | 3.45949195 |
| 38 | neural tube formation (GO:0001841) | 3.45275810 |
| 39 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.44937960 |
| 40 | positive regulation of B cell differentiation (GO:0045579) | 3.43764034 |
| 41 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.41990807 |
| 42 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.35557131 |
| 43 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.35375501 |
| 44 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.35029187 |
| 45 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.31064534 |
| 46 | synaptic vesicle maturation (GO:0016188) | 3.29577532 |
| 47 | termination of RNA polymerase III transcription (GO:0006386) | 3.20635127 |
| 48 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.20635127 |
| 49 | interkinetic nuclear migration (GO:0022027) | 3.19917206 |
| 50 | synaptic transmission, glutamatergic (GO:0035249) | 3.19785807 |
| 51 | postsynaptic membrane organization (GO:0001941) | 3.14860146 |
| 52 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.14359480 |
| 53 | atrial cardiac muscle cell action potential (GO:0086014) | 3.10741907 |
| 54 | regulation of mRNA splicing, via spliceosome (GO:0048024) | 3.09771786 |
| 55 | startle response (GO:0001964) | 3.08960962 |
| 56 | regulation of synaptic vesicle transport (GO:1902803) | 3.07800050 |
| 57 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.04762032 |
| 58 | transmission of nerve impulse (GO:0019226) | 3.04578851 |
| 59 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.02940945 |
| 60 | interferon-gamma production (GO:0032609) | 3.02652054 |
| 61 | viral mRNA export from host cell nucleus (GO:0046784) | 3.01915195 |
| 62 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.01766661 |
| 63 | establishment of protein localization to Golgi (GO:0072600) | 3.01214887 |
| 64 | righting reflex (GO:0060013) | 3.00726293 |
| 65 | negative regulation of mRNA processing (GO:0050686) | 2.96804667 |
| 66 | neuron-neuron synaptic transmission (GO:0007270) | 2.96216067 |
| 67 | response to pheromone (GO:0019236) | 2.95541713 |
| 68 | regulation of histone H3-K27 methylation (GO:0061085) | 2.95172943 |
| 69 | peptidyl-lysine trimethylation (GO:0018023) | 2.94737809 |
| 70 | presynaptic membrane organization (GO:0097090) | 2.93434486 |
| 71 | regulation of neurotransmitter secretion (GO:0046928) | 2.93035180 |
| 72 | regulation of gamma-delta T cell activation (GO:0046643) | 2.92604810 |
| 73 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.89729927 |
| 74 | regulation of relaxation of muscle (GO:1901077) | 2.88693203 |
| 75 | cell wall macromolecule catabolic process (GO:0016998) | 2.86340204 |
| 76 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.86028814 |
| 77 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.86028814 |
| 78 | regulation of B cell differentiation (GO:0045577) | 2.84204409 |
| 79 | epithelial cilium movement (GO:0003351) | 2.83034104 |
| 80 | B cell receptor signaling pathway (GO:0050853) | 2.82897114 |
| 81 | positive T cell selection (GO:0043368) | 2.82835137 |
| 82 | regulation of germinal center formation (GO:0002634) | 2.82524580 |
| 83 | histone H2A acetylation (GO:0043968) | 2.81426982 |
| 84 | cellular potassium ion homeostasis (GO:0030007) | 2.75910595 |
| 85 | protein targeting to Golgi (GO:0000042) | 2.75531668 |
| 86 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.75143228 |
| 87 | neurotransmitter secretion (GO:0007269) | 2.75114509 |
| 88 | positive regulation of membrane potential (GO:0045838) | 2.74118831 |
| 89 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 2.74062528 |
| 90 | long-term memory (GO:0007616) | 2.72552468 |
| 91 | termination of RNA polymerase II transcription (GO:0006369) | 2.71794588 |
| 92 | microglial cell activation (GO:0001774) | 2.70309762 |
| 93 | protein localization to cilium (GO:0061512) | 2.69495209 |
| 94 | DNA topological change (GO:0006265) | 2.69258672 |
| 95 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.68340867 |
| 96 | cilium movement (GO:0003341) | 2.65255195 |
| 97 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.64979759 |
| 98 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.64631879 |
| 99 | calcium ion import (GO:0070509) | 2.64453961 |
| 100 | cell wall macromolecule metabolic process (GO:0044036) | 2.64235320 |
| 101 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.63734827 |
| 102 | regulation of neurotransmitter transport (GO:0051588) | 2.63656313 |
| 103 | regulation of development, heterochronic (GO:0040034) | 2.63578220 |
| 104 | visual perception (GO:0007601) | 2.61918290 |
| 105 | sensory perception of light stimulus (GO:0050953) | 2.61352323 |
| 106 | axoneme assembly (GO:0035082) | 2.61035800 |
| 107 | dendrite morphogenesis (GO:0048813) | 2.59834395 |
| 108 | regulation of cilium movement (GO:0003352) | 2.59293345 |
| 109 | histone H3-K9 modification (GO:0061647) | 2.58831029 |
| 110 | mast cell activation (GO:0045576) | 2.57979435 |
| 111 | negative regulation of mRNA metabolic process (GO:1903312) | 2.57968777 |
| 112 | vocalization behavior (GO:0071625) | 2.57006207 |
| 113 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.56607332 |
| 114 | negative regulation of cell killing (GO:0031342) | 2.56607332 |
| 115 | neuronal action potential (GO:0019228) | 2.56599095 |
| 116 | regulation of mRNA processing (GO:0050684) | 2.55941115 |
| 117 | membrane depolarization during action potential (GO:0086010) | 2.55517304 |
| 118 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.55198142 |
| 119 | regulation of pigment cell differentiation (GO:0050932) | 2.54730765 |
| 120 | membrane hyperpolarization (GO:0060081) | 2.54036350 |
| 121 | innervation (GO:0060384) | 2.53662857 |
| 122 | sodium ion export (GO:0071436) | 2.53236850 |
| 123 | protein K11-linked deubiquitination (GO:0035871) | 2.52651470 |
| 124 | histone H3-K9 methylation (GO:0051567) | 2.52398033 |
| 125 | synaptic vesicle endocytosis (GO:0048488) | 2.51652279 |
| 126 | response to auditory stimulus (GO:0010996) | 2.51295279 |
| 127 | cellular response to interleukin-15 (GO:0071350) | 2.50635991 |
| 128 | regulation of vesicle fusion (GO:0031338) | 2.49649673 |
| 129 | positive regulation of mRNA catabolic process (GO:0061014) | 2.49632290 |
| 130 | detection of light stimulus (GO:0009583) | 2.49571473 |
| 131 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.49477408 |
| 132 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.49017493 |
| 133 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.48358631 |
| 134 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.47756039 |
| 135 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.47680788 |
| 136 | mast cell activation involved in immune response (GO:0002279) | 2.47178980 |
| 137 | mast cell degranulation (GO:0043303) | 2.47178980 |
| 138 | neurotransmitter transport (GO:0006836) | 2.47079593 |
| 139 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.47000583 |
| 140 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.47000583 |
| 141 | positive regulation of developmental pigmentation (GO:0048087) | 2.46946606 |
| 142 | positive regulation of synapse maturation (GO:0090129) | 2.46011702 |
| 143 | mitotic sister chromatid cohesion (GO:0007064) | 2.45543674 |
| 144 | inositol phosphate dephosphorylation (GO:0046855) | 2.45180765 |
| 145 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.45180765 |
| 146 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.44499875 |
| 147 | seminiferous tubule development (GO:0072520) | 2.44214685 |
| 148 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.44190090 |
| 149 | response to interleukin-15 (GO:0070672) | 2.43034335 |
| 150 | detection of visible light (GO:0009584) | 2.42997720 |
| 151 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.42307356 |
| 152 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.42307356 |
| 153 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.41843351 |
| 154 | DNA-templated transcription, termination (GO:0006353) | 2.41741036 |
| 155 | L-fucose catabolic process (GO:0042355) | 2.37894234 |
| 156 | fucose catabolic process (GO:0019317) | 2.37894234 |
| 157 | L-fucose metabolic process (GO:0042354) | 2.37894234 |
| 158 | regulation of granulocyte differentiation (GO:0030852) | 2.37609338 |
| 159 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.36679922 |
| 160 | T cell migration (GO:0072678) | 2.36565272 |
| 161 | negative regulation of T cell mediated immunity (GO:0002710) | 2.35631504 |
| 162 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.35402669 |
| 163 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.35402669 |
| 164 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.35402669 |
| 165 | cAMP catabolic process (GO:0006198) | 2.33979008 |
| 166 | protein complex biogenesis (GO:0070271) | 2.32138414 |
| 167 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.31726310 |
| 168 | cellular response to ethanol (GO:0071361) | 2.31106152 |
| 169 | positive thymic T cell selection (GO:0045059) | 2.29639412 |
| 170 | indolalkylamine metabolic process (GO:0006586) | 2.29233014 |
| 171 | monoamine transport (GO:0015844) | 2.28621939 |
| 172 | dopamine transport (GO:0015872) | 2.28142852 |
| 173 | DNA demethylation (GO:0080111) | 2.25702010 |
| 174 | cyclic nucleotide catabolic process (GO:0009214) | 2.25064934 |
| 175 | protein localization to Golgi apparatus (GO:0034067) | 2.24477927 |
| 176 | T cell selection (GO:0045058) | 2.24451100 |
| 177 | inositol phosphate catabolic process (GO:0071545) | 2.24307182 |
| 178 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.22809091 |
| 179 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.22564102 |
| 180 | dentate gyrus development (GO:0021542) | 2.21208376 |
| 181 | aggressive behavior (GO:0002118) | 2.20738296 |
| 182 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.20671316 |
| 183 | NADH dehydrogenase complex assembly (GO:0010257) | 2.20671316 |
| 184 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.20671316 |
| 185 | neutrophil mediated immunity (GO:0002446) | 2.19151787 |
| 186 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.18650771 |
| 187 | negative regulation of adaptive immune response (GO:0002820) | 2.18066492 |
| 188 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.17622645 |
| 189 | gamma-aminobutyric acid transport (GO:0015812) | 2.16830876 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.95686748 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.53080623 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.21290520 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.15099763 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.97558820 |
| 6 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.87934360 |
| 7 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.72566261 |
| 8 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.67431616 |
| 9 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.65432877 |
| 10 | FUS_26573619_Chip-Seq_HEK293_Human | 2.59808535 |
| 11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.49718491 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.40539924 |
| 13 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.33949363 |
| 14 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.25144275 |
| 15 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.20632338 |
| 16 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.19923809 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.18146549 |
| 18 | EWS_26573619_Chip-Seq_HEK293_Human | 2.17574698 |
| 19 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.16195737 |
| 20 | VDR_22108803_ChIP-Seq_LS180_Human | 2.15677228 |
| 21 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.08460978 |
| 22 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.05653273 |
| 23 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.04452253 |
| 24 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.99395556 |
| 25 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.94721125 |
| 26 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.90275310 |
| 27 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.89353565 |
| 28 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.79767041 |
| 29 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.78972640 |
| 30 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.77602463 |
| 31 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.74826590 |
| 32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.74656823 |
| 33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.70985715 |
| 34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.70562057 |
| 35 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.68603332 |
| 36 | P300_19829295_ChIP-Seq_ESCs_Human | 1.68487909 |
| 37 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.63484474 |
| 38 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.58993258 |
| 39 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.58655755 |
| 40 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.52866316 |
| 41 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.50514042 |
| 42 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.50484986 |
| 43 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.50420176 |
| 44 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.48987403 |
| 45 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.48987403 |
| 46 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.47516981 |
| 47 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.47127804 |
| 48 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.46798063 |
| 49 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.46217208 |
| 50 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.43805776 |
| 51 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.43805776 |
| 52 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.43034906 |
| 53 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.41818229 |
| 54 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.41171722 |
| 55 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.39873454 |
| 56 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.39819052 |
| 57 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.39269039 |
| 58 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.37257382 |
| 59 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.36916971 |
| 60 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.36373234 |
| 61 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.35558359 |
| 62 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.35310317 |
| 63 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.35225485 |
| 64 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.34856952 |
| 65 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.33707999 |
| 66 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.33510385 |
| 67 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.33504270 |
| 68 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.32856820 |
| 69 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.30627440 |
| 70 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.30478496 |
| 71 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.29212268 |
| 72 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.27753738 |
| 73 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.27544137 |
| 74 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26875282 |
| 75 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.26685923 |
| 76 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.26402740 |
| 77 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.25277465 |
| 78 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.24186980 |
| 79 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.24094529 |
| 80 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.23623440 |
| 81 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23358488 |
| 82 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.23267013 |
| 83 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.22969463 |
| 84 | STAT3_23295773_ChIP-Seq_U87_Human | 1.21718684 |
| 85 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20775036 |
| 86 | GATA3_26560356_Chip-Seq_TH2_Human | 1.20199442 |
| 87 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.20144213 |
| 88 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.18922602 |
| 89 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.17732168 |
| 90 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.17307074 |
| 91 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.17299524 |
| 92 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.17087066 |
| 93 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.16199012 |
| 94 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.15492751 |
| 95 | MYB_26560356_Chip-Seq_TH2_Human | 1.14672513 |
| 96 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.14329879 |
| 97 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.13991495 |
| 98 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13888820 |
| 99 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.13074447 |
| 100 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.12177116 |
| 101 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.11623071 |
| 102 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.10540118 |
| 103 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.10289619 |
| 104 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.10046067 |
| 105 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09655880 |
| 106 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.08411652 |
| 107 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07908813 |
| 108 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.07380578 |
| 109 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.07378898 |
| 110 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.07319539 |
| 111 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.07219494 |
| 112 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.06868942 |
| 113 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.06868942 |
| 114 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.06729091 |
| 115 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.06031882 |
| 116 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.05733657 |
| 117 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.05447291 |
| 118 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.05236518 |
| 119 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.05170241 |
| 120 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.04214406 |
| 121 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.03569393 |
| 122 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.01899091 |
| 123 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.01578850 |
| 124 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.01288282 |
| 125 | AR_25329375_ChIP-Seq_VCAP_Human | 1.00516587 |
| 126 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00341895 |
| 127 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.99428912 |
| 128 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.99082400 |
| 129 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.98775081 |
| 130 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97891503 |
| 131 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97650255 |
| 132 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.97506977 |
| 133 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.97442032 |
| 134 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.97215517 |
| 135 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.96462065 |
| 136 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.96307954 |
| 137 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.96098621 |
| 138 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96085215 |
| 139 | TP53_16413492_ChIP-PET_HCT116_Human | 0.95935865 |
| 140 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.95906057 |
| 141 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.95480407 |
| 142 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.95324827 |
| 143 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.95009722 |
| 144 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94902092 |
| 145 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.94420811 |
| 146 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.94402982 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005551_abnormal_eye_electrophysiolog | 4.52585754 |
| 2 | MP0006072_abnormal_retinal_apoptosis | 4.39264495 |
| 3 | MP0006292_abnormal_olfactory_placode | 3.36278193 |
| 4 | MP0005253_abnormal_eye_physiology | 3.09536730 |
| 5 | MP0003880_abnormal_central_pattern | 2.70267885 |
| 6 | MP0003787_abnormal_imprinting | 2.67849092 |
| 7 | MP0005423_abnormal_somatic_nervous | 2.65408340 |
| 8 | MP0001984_abnormal_olfaction | 2.64662978 |
| 9 | MP0002638_abnormal_pupillary_reflex | 2.62092341 |
| 10 | MP0001188_hyperpigmentation | 2.61117096 |
| 11 | MP0004859_abnormal_synaptic_plasticity | 2.48336645 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.42756523 |
| 13 | MP0001486_abnormal_startle_reflex | 2.37332838 |
| 14 | MP0004270_analgesia | 2.35986602 |
| 15 | MP0005646_abnormal_pituitary_gland | 2.34371076 |
| 16 | MP0003635_abnormal_synaptic_transmissio | 2.31666294 |
| 17 | MP0009046_muscle_twitch | 2.17667235 |
| 18 | MP0003011_delayed_dark_adaptation | 2.02971482 |
| 19 | MP0003195_calcinosis | 2.01113579 |
| 20 | MP0001502_abnormal_circadian_rhythm | 1.95494662 |
| 21 | MP0009745_abnormal_behavioral_response | 1.91672628 |
| 22 | MP0003724_increased_susceptibility_to | 1.91376648 |
| 23 | MP0002272_abnormal_nervous_system | 1.84890951 |
| 24 | MP0002009_preneoplasia | 1.84317973 |
| 25 | MP0008995_early_reproductive_senescence | 1.83217016 |
| 26 | MP0005195_abnormal_posterior_eye | 1.81856021 |
| 27 | MP0002734_abnormal_mechanical_nocicepti | 1.80853131 |
| 28 | MP0001800_abnormal_humoral_immune | 1.79841269 |
| 29 | MP0002064_seizures | 1.79746034 |
| 30 | MP0002572_abnormal_emotion/affect_behav | 1.77806103 |
| 31 | MP0002063_abnormal_learning/memory/cond | 1.71373307 |
| 32 | MP0008877_abnormal_DNA_methylation | 1.68916023 |
| 33 | MP0004147_increased_porphyrin_level | 1.68828573 |
| 34 | MP0002067_abnormal_sensory_capabilities | 1.66980082 |
| 35 | MP0001986_abnormal_taste_sensitivity | 1.64996356 |
| 36 | MP0002229_neurodegeneration | 1.64044945 |
| 37 | MP0003890_abnormal_embryonic-extraembry | 1.63753013 |
| 38 | MP0002090_abnormal_vision | 1.58766315 |
| 39 | MP0004142_abnormal_muscle_tone | 1.55887774 |
| 40 | MP0003646_muscle_fatigue | 1.53222298 |
| 41 | MP0005075_abnormal_melanosome_morpholog | 1.48992226 |
| 42 | MP0003763_abnormal_thymus_physiology | 1.48222244 |
| 43 | MP0003121_genomic_imprinting | 1.48133378 |
| 44 | MP0002396_abnormal_hematopoietic_system | 1.46990163 |
| 45 | MP0002837_dystrophic_cardiac_calcinosis | 1.45665499 |
| 46 | MP0001501_abnormal_sleep_pattern | 1.43463398 |
| 47 | MP0010094_abnormal_chromosome_stability | 1.42539652 |
| 48 | MP0005391_vision/eye_phenotype | 1.42116787 |
| 49 | MP0002882_abnormal_neuron_morphology | 1.39392656 |
| 50 | MP0008569_lethality_at_weaning | 1.39284754 |
| 51 | MP0008007_abnormal_cellular_replicative | 1.38869555 |
| 52 | MP0000631_abnormal_neuroendocrine_gland | 1.35928435 |
| 53 | MP0001529_abnormal_vocalization | 1.35780124 |
| 54 | MP0002723_abnormal_immune_serum | 1.35747846 |
| 55 | MP0002752_abnormal_somatic_nervous | 1.35396455 |
| 56 | MP0000778_abnormal_nervous_system | 1.35126140 |
| 57 | MP0003183_abnormal_peptide_metabolism | 1.34728376 |
| 58 | MP0005394_taste/olfaction_phenotype | 1.34711416 |
| 59 | MP0005499_abnormal_olfactory_system | 1.34711416 |
| 60 | MP0002876_abnormal_thyroid_physiology | 1.34090612 |
| 61 | MP0005397_hematopoietic_system_phenotyp | 1.32425216 |
| 62 | MP0001545_abnormal_hematopoietic_system | 1.32425216 |
| 63 | MP0004924_abnormal_behavior | 1.30351497 |
| 64 | MP0005386_behavior/neurological_phenoty | 1.30351497 |
| 65 | MP0001790_abnormal_immune_system | 1.28449720 |
| 66 | MP0005387_immune_system_phenotype | 1.28449720 |
| 67 | MP0005000_abnormal_immune_tolerance | 1.28203156 |
| 68 | MP0002184_abnormal_innervation | 1.27908583 |
| 69 | MP0002420_abnormal_adaptive_immunity | 1.27374565 |
| 70 | MP0006276_abnormal_autonomic_nervous | 1.25147866 |
| 71 | MP0002822_catalepsy | 1.23788139 |
| 72 | MP0001819_abnormal_immune_cell | 1.23441727 |
| 73 | MP0008058_abnormal_DNA_repair | 1.23282839 |
| 74 | MP0000566_synostosis | 1.22442604 |
| 75 | MP0003111_abnormal_nucleus_morphology | 1.21628649 |
| 76 | MP0002452_abnormal_antigen_presenting | 1.21477554 |
| 77 | MP0002557_abnormal_social/conspecific_i | 1.18600537 |
| 78 | MP0009278_abnormal_bone_marrow | 1.17104522 |
| 79 | MP0002653_abnormal_ependyma_morphology | 1.15214596 |
| 80 | MP0002736_abnormal_nociception_after | 1.13120620 |
| 81 | MP0006035_abnormal_mitochondrial_morpho | 1.12751186 |
| 82 | MP0003045_fibrosis | 1.12572146 |
| 83 | MP0000955_abnormal_spinal_cord | 1.09965703 |
| 84 | MP0008872_abnormal_physiological_respon | 1.09424103 |
| 85 | MP0001440_abnormal_grooming_behavior | 1.08669991 |
| 86 | MP0005645_abnormal_hypothalamus_physiol | 1.08553725 |
| 87 | MP0002928_abnormal_bile_duct | 1.08226718 |
| 88 | MP0002398_abnormal_bone_marrow | 1.08122628 |
| 89 | MP0010386_abnormal_urinary_bladder | 1.07740178 |
| 90 | MP0000372_irregular_coat_pigmentation | 1.07599474 |
| 91 | MP0009785_altered_susceptibility_to | 1.07404595 |
| 92 | MP0002277_abnormal_respiratory_mucosa | 1.06085776 |
| 93 | MP0008789_abnormal_olfactory_epithelium | 1.05491463 |
| 94 | MP0002132_abnormal_respiratory_system | 1.04415560 |
| 95 | MP0000716_abnormal_immune_system | 1.03558314 |
| 96 | MP0005379_endocrine/exocrine_gland_phen | 1.02031800 |
| 97 | MP0005025_abnormal_response_to | 1.01660854 |
| 98 | MP0004215_abnormal_myocardial_fiber | 1.01645576 |
| 99 | MP0002152_abnormal_brain_morphology | 1.01259119 |
| 100 | MP0001968_abnormal_touch/_nociception | 1.00217543 |
| 101 | MP0001485_abnormal_pinna_reflex | 0.97869585 |
| 102 | MP0009697_abnormal_copulation | 0.97126766 |
| 103 | MP0002419_abnormal_innate_immunity | 0.95932298 |
| 104 | MP0001324_abnormal_eye_pigmentation | 0.95240658 |
| 105 | MP0000689_abnormal_spleen_morphology | 0.94992930 |
| 106 | MP0005535_abnormal_body_temperature | 0.94005453 |
| 107 | MP0004043_abnormal_pH_regulation | 0.93350541 |
| 108 | MP0001963_abnormal_hearing_physiology | 0.89596971 |
| 109 | MP0002102_abnormal_ear_morphology | 0.88468301 |
| 110 | MP0008057_abnormal_DNA_replication | 0.88080729 |
| 111 | MP0004484_altered_response_of | 0.87192772 |
| 112 | MP0005174_abnormal_tail_pigmentation | 0.86728373 |
| 113 | MP0000685_abnormal_immune_system | 0.85997045 |
| 114 | MP0002148_abnormal_hypersensitivity_rea | 0.84947473 |
| 115 | MP0002066_abnormal_motor_capabilities/c | 0.84910837 |
| 116 | MP0005671_abnormal_response_to | 0.84801858 |
| 117 | MP0008775_abnormal_heart_ventricle | 0.84571847 |
| 118 | MP0006036_abnormal_mitochondrial_physio | 0.84458732 |
| 119 | MP0002405_respiratory_system_inflammati | 0.84148345 |
| 120 | MP0005409_darkened_coat_color | 0.84084488 |
| 121 | MP0003866_abnormal_defecation | 0.84025249 |
| 122 | MP0001764_abnormal_homeostasis | 0.83179214 |
| 123 | MP0004084_abnormal_cardiac_muscle | 0.83008550 |
| 124 | MP0005220_abnormal_exocrine_pancreas | 0.82576309 |
| 125 | MP0002166_altered_tumor_susceptibility | 0.81685606 |
| 126 | MP0003137_abnormal_impulse_conducting | 0.81612097 |
| 127 | MP0002095_abnormal_skin_pigmentation | 0.81400717 |
| 128 | MP0002909_abnormal_adrenal_gland | 0.81195185 |
| 129 | MP0001286_abnormal_eye_development | 0.80642872 |
| 130 | MP0002138_abnormal_hepatobiliary_system | 0.79604460 |
| 131 | MP0001970_abnormal_pain_threshold | 0.79068963 |
| 132 | MP0008961_abnormal_basal_metabolism | 0.78899643 |
| 133 | MP0004130_abnormal_muscle_cell | 0.78414265 |
| 134 | MP0000703_abnormal_thymus_morphology | 0.77794208 |
| 135 | MP0003698_abnormal_male_reproductive | 0.75968946 |
| 136 | MP0003950_abnormal_plasma_membrane | 0.75301380 |
| 137 | MP0002722_abnormal_immune_system | 0.75013268 |
| 138 | MP0001873_stomach_inflammation | 0.74185955 |
| 139 | MP0004885_abnormal_endolymph | 0.73489166 |
| 140 | MP0002735_abnormal_chemical_nociception | 0.73297589 |
| 141 | MP0004742_abnormal_vestibular_system | 0.71672537 |
| 142 | MP0003861_abnormal_nervous_system | 0.71156588 |
| 143 | MP0004811_abnormal_neuron_physiology | 0.70536769 |
| 144 | MP0002733_abnormal_thermal_nociception | 0.70205068 |
| 145 | MP0001346_abnormal_lacrimal_gland | 0.69371560 |
| 146 | MP0000569_abnormal_digit_pigmentation | 0.68961124 |
| 147 | MP0002210_abnormal_sex_determination | 0.67544839 |
| 148 | MP0001929_abnormal_gametogenesis | 0.67236863 |
| 149 | MP0002163_abnormal_gland_morphology | 0.66014146 |
| 150 | MP0003077_abnormal_cell_cycle | 0.65252086 |
| 151 | MP0004145_abnormal_muscle_electrophysio | 0.64962546 |
| 152 | MP0003693_abnormal_embryo_hatching | 0.64906086 |
| 153 | MP0001661_extended_life_span | 0.63918513 |
| 154 | MP0001905_abnormal_dopamine_level | 0.63583222 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 7.28288739 |
| 2 | Central scotoma (HP:0000603) | 5.22010774 |
| 3 | Abnormal rod and cone electroretinograms (HP:0008323) | 4.38903414 |
| 4 | Severe visual impairment (HP:0001141) | 4.25107505 |
| 5 | Dyschromatopsia (HP:0007641) | 4.17706440 |
| 6 | Panhypogammaglobulinemia (HP:0003139) | 4.13943071 |
| 7 | Abnormality of macular pigmentation (HP:0008002) | 4.01500073 |
| 8 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.96737239 |
| 9 | Scotoma (HP:0000575) | 3.82598205 |
| 10 | Pendular nystagmus (HP:0012043) | 3.55450616 |
| 11 | Decreased central vision (HP:0007663) | 3.45641263 |
| 12 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.45160061 |
| 13 | Epileptic encephalopathy (HP:0200134) | 3.42610823 |
| 14 | Excessive salivation (HP:0003781) | 3.33059902 |
| 15 | Drooling (HP:0002307) | 3.33059902 |
| 16 | Pancreatic fibrosis (HP:0100732) | 3.14013551 |
| 17 | Absent/shortened dynein arms (HP:0200106) | 3.12652547 |
| 18 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.12652547 |
| 19 | Abnormality of midbrain morphology (HP:0002418) | 3.08707982 |
| 20 | Molar tooth sign on MRI (HP:0002419) | 3.08707982 |
| 21 | Attenuation of retinal blood vessels (HP:0007843) | 3.02650184 |
| 22 | Focal motor seizures (HP:0011153) | 3.02444634 |
| 23 | True hermaphroditism (HP:0010459) | 2.98747330 |
| 24 | Hyperventilation (HP:0002883) | 2.97744269 |
| 25 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.96756496 |
| 26 | Volvulus (HP:0002580) | 2.94790547 |
| 27 | Abnormality of B cell number (HP:0010975) | 2.94031705 |
| 28 | T lymphocytopenia (HP:0005403) | 2.90998732 |
| 29 | Febrile seizures (HP:0002373) | 2.89671384 |
| 30 | Abnormality of T cell number (HP:0011839) | 2.89162605 |
| 31 | Stomach cancer (HP:0012126) | 2.82539215 |
| 32 | Mutism (HP:0002300) | 2.82092672 |
| 33 | Esotropia (HP:0000565) | 2.71672685 |
| 34 | Abnormality of the renal cortex (HP:0011035) | 2.71444978 |
| 35 | Abnormality of the renal medulla (HP:0100957) | 2.71132730 |
| 36 | Pancreatic cysts (HP:0001737) | 2.70390749 |
| 37 | B lymphocytopenia (HP:0010976) | 2.69849474 |
| 38 | Chronic hepatic failure (HP:0100626) | 2.59132026 |
| 39 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.57070461 |
| 40 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.57070461 |
| 41 | Abnormal ciliary motility (HP:0012262) | 2.56742387 |
| 42 | Vitreoretinal degeneration (HP:0000655) | 2.56302466 |
| 43 | Hypoproteinemia (HP:0003075) | 2.53025894 |
| 44 | Stomatitis (HP:0010280) | 2.52090211 |
| 45 | Recurrent fungal infections (HP:0002841) | 2.49596540 |
| 46 | Impaired smooth pursuit (HP:0007772) | 2.48828266 |
| 47 | Chronic otitis media (HP:0000389) | 2.47528288 |
| 48 | Protruding tongue (HP:0010808) | 2.46165164 |
| 49 | Gaze-evoked nystagmus (HP:0000640) | 2.41958832 |
| 50 | Renal cortical cysts (HP:0000803) | 2.40238504 |
| 51 | Optic nerve coloboma (HP:0000588) | 2.39719106 |
| 52 | Bifid tongue (HP:0010297) | 2.38424353 |
| 53 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.36361551 |
| 54 | Progressive cerebellar ataxia (HP:0002073) | 2.36287609 |
| 55 | Myositis (HP:0100614) | 2.34200005 |
| 56 | Agammaglobulinemia (HP:0004432) | 2.32134358 |
| 57 | Tubulointerstitial nephritis (HP:0001970) | 2.31398555 |
| 58 | Chronic sinusitis (HP:0011109) | 2.28650629 |
| 59 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.25526411 |
| 60 | Eosinophilia (HP:0001880) | 2.25398900 |
| 61 | Birth length less than 3rd percentile (HP:0003561) | 2.24465689 |
| 62 | Gait imbalance (HP:0002141) | 2.23339745 |
| 63 | Abnormality of eosinophils (HP:0001879) | 2.23335609 |
| 64 | Combined immunodeficiency (HP:0005387) | 2.22599595 |
| 65 | Upper motor neuron abnormality (HP:0002127) | 2.22333642 |
| 66 | Keratoconus (HP:0000563) | 2.21614849 |
| 67 | Increased corneal curvature (HP:0100692) | 2.21614849 |
| 68 | Encephalitis (HP:0002383) | 2.20954287 |
| 69 | Abnormality of T cells (HP:0002843) | 2.19868718 |
| 70 | Retinitis pigmentosa (HP:0000510) | 2.19477737 |
| 71 | CNS hypomyelination (HP:0003429) | 2.18493199 |
| 72 | Photophobia (HP:0000613) | 2.17030805 |
| 73 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.15968668 |
| 74 | Hypoplasia of the fovea (HP:0007750) | 2.15968668 |
| 75 | Chorioretinal atrophy (HP:0000533) | 2.15611808 |
| 76 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.15557849 |
| 77 | Genetic anticipation (HP:0003743) | 2.14647551 |
| 78 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.13831623 |
| 79 | Absent speech (HP:0001344) | 2.13381691 |
| 80 | Recurrent cutaneous fungal infections (HP:0011370) | 2.12954439 |
| 81 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.12954439 |
| 82 | Split foot (HP:0001839) | 2.12123806 |
| 83 | Atonic seizures (HP:0010819) | 2.12011303 |
| 84 | Abnormality of salivation (HP:0100755) | 2.09516585 |
| 85 | Medial flaring of the eyebrow (HP:0010747) | 2.09397605 |
| 86 | Congenital primary aphakia (HP:0007707) | 2.09049657 |
| 87 | Median cleft lip (HP:0000161) | 2.08461805 |
| 88 | Type II diabetes mellitus (HP:0005978) | 2.07325449 |
| 89 | Oligodactyly (hands) (HP:0001180) | 2.07316283 |
| 90 | Truncal ataxia (HP:0002078) | 2.07111456 |
| 91 | Abnormality of the fovea (HP:0000493) | 2.06949931 |
| 92 | Leukocytosis (HP:0001974) | 2.06770548 |
| 93 | Granulocytopenia (HP:0001913) | 2.04724140 |
| 94 | Cystic liver disease (HP:0006706) | 2.04346743 |
| 95 | Postural tremor (HP:0002174) | 2.03737174 |
| 96 | Nephrogenic diabetes insipidus (HP:0009806) | 2.03159916 |
| 97 | Retrobulbar optic neuritis (HP:0100654) | 2.02294210 |
| 98 | Optic neuritis (HP:0100653) | 2.02294210 |
| 99 | Hypoplasia of the thymus (HP:0000778) | 1.99581770 |
| 100 | Papilledema (HP:0001085) | 1.98258202 |
| 101 | 3-Methylglutaconic aciduria (HP:0003535) | 1.98071618 |
| 102 | Broad-based gait (HP:0002136) | 1.97169918 |
| 103 | Recurrent bronchitis (HP:0002837) | 1.96946010 |
| 104 | Meningitis (HP:0001287) | 1.95859165 |
| 105 | Alveolar cell carcinoma (HP:0006519) | 1.95529259 |
| 106 | Septo-optic dysplasia (HP:0100842) | 1.94839273 |
| 107 | Dysmetria (HP:0001310) | 1.92921936 |
| 108 | Congenital hepatic fibrosis (HP:0002612) | 1.91765899 |
| 109 | Hypothermia (HP:0002045) | 1.91558529 |
| 110 | Abnormal drinking behavior (HP:0030082) | 1.90637791 |
| 111 | Polydipsia (HP:0001959) | 1.90637791 |
| 112 | Abolished electroretinogram (ERG) (HP:0000550) | 1.90020916 |
| 113 | Hypochromic microcytic anemia (HP:0004840) | 1.89648296 |
| 114 | Pigmentary retinal degeneration (HP:0001146) | 1.89221571 |
| 115 | Absence seizures (HP:0002121) | 1.88847658 |
| 116 | Scanning speech (HP:0002168) | 1.88420369 |
| 117 | Visual hallucinations (HP:0002367) | 1.86871482 |
| 118 | Thyroiditis (HP:0100646) | 1.83779577 |
| 119 | Abnormality of the columella (HP:0009929) | 1.83275920 |
| 120 | Type I transferrin isoform profile (HP:0003642) | 1.82624237 |
| 121 | Constricted visual fields (HP:0001133) | 1.81855424 |
| 122 | Widely spaced teeth (HP:0000687) | 1.81740721 |
| 123 | Choroideremia (HP:0001139) | 1.81521219 |
| 124 | Recurrent bacterial skin infections (HP:0005406) | 1.80988801 |
| 125 | Chorioretinal coloboma (HP:0000567) | 1.80955868 |
| 126 | Abnormality of the fingertips (HP:0001211) | 1.79514325 |
| 127 | Preaxial hand polydactyly (HP:0001177) | 1.77509777 |
| 128 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.76247003 |
| 129 | Recurrent viral infections (HP:0004429) | 1.75541426 |
| 130 | Thyroid-stimulating hormone excess (HP:0002925) | 1.75051180 |
| 131 | Dyskinesia (HP:0100660) | 1.74821313 |
| 132 | Mitochondrial inheritance (HP:0001427) | 1.74015597 |
| 133 | Severe combined immunodeficiency (HP:0004430) | 1.73983124 |
| 134 | Amyotrophic lateral sclerosis (HP:0007354) | 1.73862259 |
| 135 | Supernumerary spleens (HP:0009799) | 1.73230475 |
| 136 | Abnormality of the labia minora (HP:0012880) | 1.73122931 |
| 137 | Optic nerve hypoplasia (HP:0000609) | 1.72334728 |
| 138 | Neoplasm of the oral cavity (HP:0100649) | 1.71872732 |
| 139 | Hepatocellular necrosis (HP:0001404) | 1.71697705 |
| 140 | Type II lissencephaly (HP:0007260) | 1.71492341 |
| 141 | Congenital sensorineural hearing impairment (HP:0008527) | 1.71073278 |
| 142 | Genital tract atresia (HP:0001827) | 1.70694005 |
| 143 | Anencephaly (HP:0002323) | 1.69182155 |
| 144 | Highly arched eyebrow (HP:0002553) | 1.67861390 |
| 145 | Progressive inability to walk (HP:0002505) | 1.67841364 |
| 146 | Hemiparesis (HP:0001269) | 1.66353937 |
| 147 | Focal seizures (HP:0007359) | 1.66062303 |
| 148 | Postaxial foot polydactyly (HP:0001830) | 1.64349591 |
| 149 | Bile duct proliferation (HP:0001408) | 1.64329664 |
| 150 | Abnormal biliary tract physiology (HP:0012439) | 1.64329664 |
| 151 | Medulloblastoma (HP:0002885) | 1.63185159 |
| 152 | Poor coordination (HP:0002370) | 1.63019777 |
| 153 | Nephronophthisis (HP:0000090) | 1.62555615 |
| 154 | Dialeptic seizures (HP:0011146) | 1.62367740 |
| 155 | Acute lymphatic leukemia (HP:0006721) | 1.60480603 |
| 156 | Absent septum pellucidum (HP:0001331) | 1.60290427 |
| 157 | Narrow forehead (HP:0000341) | 1.59289076 |
| 158 | Macular degeneration (HP:0000608) | 1.58042393 |
| 159 | Dysdiadochokinesis (HP:0002075) | 1.57654417 |
| 160 | IgG deficiency (HP:0004315) | 1.56175329 |
| 161 | Abnormality of the septum pellucidum (HP:0007375) | 1.55818419 |
| 162 | Flat capital femoral epiphysis (HP:0003370) | 1.53505012 |
| 163 | Small hand (HP:0200055) | 1.53419025 |
| 164 | Truncal obesity (HP:0001956) | 1.53024810 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.48583798 |
| 2 | TNIK | 3.87688679 |
| 3 | SIK2 | 3.12025360 |
| 4 | TAOK3 | 2.87811272 |
| 5 | NTRK3 | 2.71180750 |
| 6 | BRD4 | 2.47743602 |
| 7 | MUSK | 2.38473808 |
| 8 | SRPK1 | 2.37319919 |
| 9 | MKNK2 | 2.31206629 |
| 10 | INSRR | 2.18811421 |
| 11 | TEC | 2.18705748 |
| 12 | MAP4K2 | 2.12186326 |
| 13 | EPHA4 | 1.96699422 |
| 14 | CCNB1 | 1.95572496 |
| 15 | CASK | 1.93943588 |
| 16 | MAP4K1 | 1.92199857 |
| 17 | DYRK1A | 1.88388382 |
| 18 | CDK12 | 1.83376752 |
| 19 | MAPK13 | 1.82183983 |
| 20 | EPHA3 | 1.75849889 |
| 21 | KIT | 1.70265288 |
| 22 | GRK1 | 1.63254794 |
| 23 | SIK3 | 1.59250339 |
| 24 | RIPK4 | 1.57503669 |
| 25 | MAP3K4 | 1.54664663 |
| 26 | CDC7 | 1.54483896 |
| 27 | NUAK1 | 1.54165930 |
| 28 | IRAK2 | 1.53647364 |
| 29 | NEK6 | 1.53238171 |
| 30 | MAP2K7 | 1.52802009 |
| 31 | ITK | 1.51434465 |
| 32 | SYK | 1.50136461 |
| 33 | NLK | 1.46292193 |
| 34 | NME1 | 1.45333822 |
| 35 | MARK1 | 1.45306633 |
| 36 | TNK2 | 1.40894364 |
| 37 | PIK3CG | 1.35659533 |
| 38 | SGK2 | 1.35183453 |
| 39 | OBSCN | 1.33891605 |
| 40 | BTK | 1.33041363 |
| 41 | ERBB3 | 1.33024385 |
| 42 | TXK | 1.32311378 |
| 43 | ACVR1B | 1.31782295 |
| 44 | MKNK1 | 1.26946924 |
| 45 | FLT3 | 1.21957787 |
| 46 | CDK3 | 1.20642972 |
| 47 | MAP3K13 | 1.19266197 |
| 48 | ADRBK2 | 1.18903081 |
| 49 | PNCK | 1.18864439 |
| 50 | DYRK3 | 1.18735676 |
| 51 | SGK223 | 1.18692579 |
| 52 | SGK494 | 1.18692579 |
| 53 | NTRK2 | 1.16790129 |
| 54 | CSF1R | 1.15096909 |
| 55 | WNK3 | 1.14306187 |
| 56 | CAMKK2 | 1.12201567 |
| 57 | CDK8 | 1.11122866 |
| 58 | IKBKE | 1.09062407 |
| 59 | PRKD3 | 1.06480512 |
| 60 | HIPK2 | 1.05660079 |
| 61 | LYN | 1.02510232 |
| 62 | FGFR2 | 1.01456267 |
| 63 | OXSR1 | 1.01235027 |
| 64 | PRKAA2 | 1.00798193 |
| 65 | MARK3 | 0.96900373 |
| 66 | PAK3 | 0.93926113 |
| 67 | BLK | 0.91901773 |
| 68 | LCK | 0.91502667 |
| 69 | IRAK1 | 0.91013290 |
| 70 | MAPK15 | 0.90363584 |
| 71 | PTK2B | 0.88816516 |
| 72 | PHKG2 | 0.88319018 |
| 73 | PHKG1 | 0.88319018 |
| 74 | VRK1 | 0.87500202 |
| 75 | MAP3K7 | 0.87418999 |
| 76 | RPS6KB1 | 0.87381751 |
| 77 | STK16 | 0.87117522 |
| 78 | EIF2AK2 | 0.87000174 |
| 79 | PRKCQ | 0.83580872 |
| 80 | TYK2 | 0.83360444 |
| 81 | AKT3 | 0.82641841 |
| 82 | CHEK2 | 0.80380667 |
| 83 | TLK1 | 0.79750873 |
| 84 | ATR | 0.79684639 |
| 85 | STK11 | 0.79182142 |
| 86 | CDK9 | 0.78629914 |
| 87 | SGK1 | 0.78547252 |
| 88 | PRKCE | 0.78523495 |
| 89 | JAK3 | 0.77883678 |
| 90 | RPS6KA5 | 0.77536594 |
| 91 | PRKCG | 0.76570592 |
| 92 | IKBKB | 0.76090677 |
| 93 | BMPR2 | 0.75461447 |
| 94 | MARK2 | 0.74021523 |
| 95 | SIK1 | 0.73605396 |
| 96 | DAPK2 | 0.73415713 |
| 97 | YES1 | 0.72629297 |
| 98 | HCK | 0.72554173 |
| 99 | GRK6 | 0.72011117 |
| 100 | JAK1 | 0.71291271 |
| 101 | MAP3K9 | 0.70969992 |
| 102 | GRK7 | 0.70034050 |
| 103 | MAP2K6 | 0.69589168 |
| 104 | ZAK | 0.67742217 |
| 105 | PRKD2 | 0.66802302 |
| 106 | SGK3 | 0.66555358 |
| 107 | MAPK10 | 0.66269446 |
| 108 | IRAK4 | 0.65328048 |
| 109 | BCR | 0.65268535 |
| 110 | CDK1 | 0.65228746 |
| 111 | PINK1 | 0.64855828 |
| 112 | ADRBK1 | 0.63531916 |
| 113 | TRPM7 | 0.63114956 |
| 114 | ATM | 0.63064596 |
| 115 | FGFR3 | 0.62820263 |
| 116 | PKN1 | 0.62227665 |
| 117 | MAPK12 | 0.61746804 |
| 118 | RPS6KA3 | 0.59971202 |
| 119 | ZAP70 | 0.59554836 |
| 120 | UHMK1 | 0.59245408 |
| 121 | CAMK1G | 0.58948507 |
| 122 | CDK5 | 0.57207943 |
| 123 | GSK3B | 0.56775374 |
| 124 | PRKAA1 | 0.56129399 |
| 125 | PRKCB | 0.55367573 |
| 126 | CSNK1A1L | 0.55356071 |
| 127 | TRIM28 | 0.55177617 |
| 128 | DYRK2 | 0.54486628 |
| 129 | PRKG1 | 0.53973217 |
| 130 | BMPR1B | 0.53913814 |
| 131 | MAPK7 | 0.53352675 |
| 132 | CAMKK1 | 0.52606093 |
| 133 | CDK2 | 0.51920294 |
| 134 | PLK3 | 0.51781182 |
| 135 | PLK1 | 0.50727494 |
| 136 | PRKDC | 0.50453169 |
| 137 | JAK2 | 0.50412982 |
| 138 | BRAF | 0.50151295 |
| 139 | WNK1 | 0.48311475 |
| 140 | BUB1 | 0.47796694 |
| 141 | CSK | 0.46428751 |
| 142 | MAPK14 | 0.46263031 |
| 143 | TBK1 | 0.46085581 |
| 144 | AURKB | 0.45902359 |
| 145 | PRKACA | 0.45794640 |
| 146 | DYRK1B | 0.44680399 |
| 147 | EIF2AK1 | 0.44376602 |
| 148 | FES | 0.43876773 |
| 149 | PRKCH | 0.43753843 |
| 150 | CAMK2A | 0.43499341 |
| 151 | MAPK8 | 0.43248543 |
| 152 | PAK6 | 0.42691499 |
| 153 | PLK2 | 0.42620348 |
| 154 | CDC42BPA | 0.42341105 |
| 155 | CAMK1 | 0.42263002 |
| 156 | MAP2K4 | 0.42070943 |
| 157 | CHEK1 | 0.41718430 |
| 158 | FGR | 0.40539626 |
| 159 | CDK19 | 0.38942590 |
| 160 | TGFBR1 | 0.38757319 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 5.28071933 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 4.14424634 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.95286118 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 2.82870724 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.68079638 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.54898739 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.41930848 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.23757967 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.21089187 |
| 10 | Spliceosome_Homo sapiens_hsa03040 | 2.02993829 |
| 11 | Circadian rhythm_Homo sapiens_hsa04710 | 2.02863287 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 2.00991716 |
| 13 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.81984617 |
| 14 | RNA degradation_Homo sapiens_hsa03018 | 1.79635613 |
| 15 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.79285868 |
| 16 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.77803662 |
| 17 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.71829373 |
| 18 | Taste transduction_Homo sapiens_hsa04742 | 1.71725478 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 1.69633276 |
| 20 | Alcoholism_Homo sapiens_hsa05034 | 1.63798606 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.59310888 |
| 22 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.57967494 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.54638864 |
| 24 | Long-term potentiation_Homo sapiens_hsa04720 | 1.53402672 |
| 25 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.52556650 |
| 26 | Homologous recombination_Homo sapiens_hsa03440 | 1.49864167 |
| 27 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.49545258 |
| 28 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.48769777 |
| 29 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.48574967 |
| 30 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.46825070 |
| 31 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.45615136 |
| 32 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.42165923 |
| 33 | Basal transcription factors_Homo sapiens_hsa03022 | 1.40476832 |
| 34 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.40078407 |
| 35 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.37496974 |
| 36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.33026518 |
| 37 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.32742366 |
| 38 | Renin secretion_Homo sapiens_hsa04924 | 1.28690366 |
| 39 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.26264094 |
| 40 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.23731595 |
| 41 | Leishmaniasis_Homo sapiens_hsa05140 | 1.23664051 |
| 42 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.23208318 |
| 43 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.22892787 |
| 44 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.22815757 |
| 45 | Parkinsons disease_Homo sapiens_hsa05012 | 1.22538542 |
| 46 | DNA replication_Homo sapiens_hsa03030 | 1.22107794 |
| 47 | Salivary secretion_Homo sapiens_hsa04970 | 1.21780995 |
| 48 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.20986742 |
| 49 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.19113701 |
| 50 | Purine metabolism_Homo sapiens_hsa00230 | 1.18529564 |
| 51 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.17527731 |
| 52 | Mismatch repair_Homo sapiens_hsa03430 | 1.17248763 |
| 53 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.14667629 |
| 54 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.12565702 |
| 55 | Cell cycle_Homo sapiens_hsa04110 | 1.08236323 |
| 56 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.07770225 |
| 57 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.05256820 |
| 58 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.04235572 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.03604683 |
| 60 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.03588055 |
| 61 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.01731697 |
| 62 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.01282351 |
| 63 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.00715565 |
| 64 | Long-term depression_Homo sapiens_hsa04730 | 0.99557705 |
| 65 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.98298399 |
| 66 | Allograft rejection_Homo sapiens_hsa05330 | 0.97534031 |
| 67 | Protein export_Homo sapiens_hsa03060 | 0.95290955 |
| 68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.94856520 |
| 69 | Cocaine addiction_Homo sapiens_hsa05030 | 0.94778219 |
| 70 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.94088202 |
| 71 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.93735717 |
| 72 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.93530191 |
| 73 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.93008986 |
| 74 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.87545522 |
| 75 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.85863243 |
| 76 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.85285931 |
| 77 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.81748679 |
| 78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.81286387 |
| 79 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.80749132 |
| 80 | Platelet activation_Homo sapiens_hsa04611 | 0.78511137 |
| 81 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.77476402 |
| 82 | Measles_Homo sapiens_hsa05162 | 0.77023073 |
| 83 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.76617092 |
| 84 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.74154778 |
| 85 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72944614 |
| 86 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.72808111 |
| 87 | Alzheimers disease_Homo sapiens_hsa05010 | 0.72785234 |
| 88 | Peroxisome_Homo sapiens_hsa04146 | 0.72753705 |
| 89 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.72103072 |
| 90 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.71439662 |
| 91 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.70891789 |
| 92 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.69039997 |
| 93 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.67835456 |
| 94 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.67792313 |
| 95 | RNA transport_Homo sapiens_hsa03013 | 0.66956360 |
| 96 | Tuberculosis_Homo sapiens_hsa05152 | 0.65118087 |
| 97 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64781491 |
| 98 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.64320336 |
| 99 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.63898214 |
| 100 | Huntingtons disease_Homo sapiens_hsa05016 | 0.63853417 |
| 101 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.63329684 |
| 102 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.62390493 |
| 103 | Base excision repair_Homo sapiens_hsa03410 | 0.62098297 |
| 104 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.60774511 |
| 105 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.60759044 |
| 106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60721478 |
| 107 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.60533446 |
| 108 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.59084922 |
| 109 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.57373875 |
| 110 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.56203032 |
| 111 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.56067501 |
| 112 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.55306337 |
| 113 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.54169174 |
| 114 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.53705302 |
| 115 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.53518105 |
| 116 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.52976900 |
| 117 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52883048 |
| 118 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.52612951 |
| 119 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.51859432 |
| 120 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.50677812 |
| 121 | Viral myocarditis_Homo sapiens_hsa05416 | 0.49371866 |
| 122 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.47977853 |
| 123 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44414847 |
| 124 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43533805 |
| 125 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42915195 |
| 126 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41486930 |
| 127 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40831991 |
| 128 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39523327 |
| 129 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38316627 |
| 130 | Lysine degradation_Homo sapiens_hsa00310 | 0.38301532 |
| 131 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.37170414 |
| 132 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.36229323 |
| 133 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.34837629 |
| 134 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.34648549 |
| 135 | Gap junction_Homo sapiens_hsa04540 | 0.34071866 |
| 136 | Axon guidance_Homo sapiens_hsa04360 | 0.33561073 |
| 137 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.32935910 |
| 138 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.30866377 |
| 139 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.30170593 |
| 140 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.27517183 |
| 141 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.27486936 |
| 142 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.27407036 |
| 143 | Asthma_Homo sapiens_hsa05310 | 0.26716204 |
| 144 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.26092863 |
| 145 | ABC transporters_Homo sapiens_hsa02010 | 0.25213274 |

